India to Netherlands: Moxifloxacin Export Trade Route

The India to Netherlands Moxifloxacin corridor is one of India's established pharmaceutical export routes, with 46 shipments documented worth a combined $1.7M USD. The route is dominated by MSN LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 69% of all export value, reflecting the consolidated nature of India's moxifloxacin manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $36.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with moxifloxacin's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 10.9%, placing it at rank #17 among India's top moxifloxacin export destinations globally.

On the import side, key buyers of Indian moxifloxacin in Netherlands include I+ SOLUTIONS,, TO THE ORDER OF, I+SOLUTIONS and 12 others. I+ SOLUTIONS, is the single largest importer with 7 shipments valued at $485.2K USD.

India's moxifloxacin exports to Netherlands are driven primarily by a handful of large-scale manufacturers. MSN LABORATORIES PRIVATE LIMITED with 22 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Netherlands benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MSN LABORATORIES PRIVATE LIMITED, MSN LABORATORIES PRIVATE LIMITED , MACLEODS PHARMACEUTICALS LTD — together account for 95% of total trade value on this route. The average shipment value of $36.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as floxsafe 400mg(moxifloxacin 400mg)fca +pfrc 10x10snos and floxsafe 400mgmoxifloxacin 400mgfca +pfrc 10x10s, suggesting that buyers in Netherlands tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, I+ SOLUTIONS, is the largest importer with 7 shipments worth $485.2K USD — representing 29% of all moxifloxacin imports from India on this route. A total of 15 buyers are active on this corridor.